Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. (ticker: DYNS) is the post-combination entity formed through the de-SPAC merger between Dynamics Special Purpose Corp and Senti Biosciences, a clinical-stage biotechnology company developing gene circuit medicines. Dynamics Special Purpose Corp completed its blank-check IPO in 2021 and closed the business combination in 2022, listing the combined life sciences platform on Nasdaq. The company submitted an 8-K current report to the SEC on July 12, 2024, disclosing a material corporate development in the biotechnology sector. For full filing history, deal terms, sponsor details, and real-time SPAC analytics on DYNS and hundreds of other vehicles, sign up for complete access at SpacDesk.